CapMan Life Science

CapMan Life Science invests mainly in Nordic healthcare service providers and in in medtech companies. Life Science investments have been part of CapMan’s investment activities since 2002. Our team has a unique experience in Nordic life science sector and we are one of the few investment teams focusing on life science investments. We work closely with the other CapMan investment teams and have made several co-investments with them in order to be able to invest in bigger healthcare service providers.  

We support our portfolio companies by ensuring them sufficient capital for growth and providing team’s cross-competency in e.g. commercialization and finance.

Our strengths

  • Teams extensive experience both in private equity and in the Nordic life science industry
  • More than 50 years' accumulated experience within life sciences and healthcare market
  • Comprehensive contact networks in Europe, particularly in the Nordic countries

latest investment

CapMan Life Science IV fund invests in Hermelinen, a Swedish private healthcare centre.  
Read release...

life science portfolio

Read more about CapMan Life Science's current portfolio companies and exited investments.

Case examples

Neoventa’s core product STAN® was introduced to the US market in 2007. Read more...